Endothelial dysfunction in psoriasis patients: Cross-sectional case-control study

European Journal of Dermatology

Volumn 21, Issue 4, 2011, Pages 510-514

  De Simone, Clara ^a   Di Giorgio, Angela ^a   Sisto, Teresa ^a   Carbone, Angelo ^a   Ghitti, Francesca ^a   Tondi, Paolo ^a   Santoliquido, Angelo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atherosclerosis; Cardiovascular risk; Endothelial dysfunction; Psoriasis

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; HUMAN; MALE; NITROGLYCERIN INDUCED DILATION; NON INVASIVE MEASUREMENT; PSORIASIS; VASODILATATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 80053007633     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1324     Document Type: Article

References (31)

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
2. Frostegård J. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005; 257: 485-95.
3. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008; 121: S21-S31.
4. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361: 496-509.
5. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
6. Gelfand JM, Neimann AL, Shin DB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
7. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.
8. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
9. Boehncke WH, Boehncke S, Schön MP. Managing comorbid disease in patients with psoriasis. BMJ 2010; 340: 200-3.
10. Vita JA, Keaney Jr JF. Endothelial function: a barometer for cardiovascular risk? Circulation 2002; 106: 640-2.
11. Coretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
12. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
13. Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008; 26: S62-5.
14. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007; 36: 203-9.
15. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007; 57: 287-93.
16. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007; 57: 1074-80.
17. Tam LS, Shang Q, Li EK, et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 2008; 59: 1322-31.
18. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gonzalez-Juanatey C, Llorca J. Subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol 2008; 35: 2070-1.
19. Soy M, Yildiz M, Sevki Uyanik M, et al. Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement. Rev Esp Cardiol 2009; 62: 96-9.
20. Balci DD, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1-6.
21. Gisondi P, Fantin F, Del Giglio M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-3.
22. El-Mongy S, Fathy H, Abdelaziz A, et al. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Eur Acad Dermatol Venereol 2009; 24: 661-6.
23. Ulusoy RE, Karabudak O, Yokusoglu M, et al. Noninvasive assessment of impaired endothelial function in psoriasis. Rheumatol Int 2010; 30: 479-83.
24. Yiu KH, Yeung CK, Chan HT, et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol 2011; article online in advance of print.
25. Martyn-Simmons CL, Ranawaka RR, Chowienczyk P, et al. A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis. Br J Dermatol 2011; 164: 26-32.
26. Galarraga B, Belch JJ, Pullar T, et al. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. Rheumatol 2010; 37: 521-8.
27. Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127: 89-97.
28. Wakkee M, Thio HB, Prens EP, et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007; 190: 1-9.
29. Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol 1999; 41: 7-12.
30. Bowden DW, Rudock M, Ziegler J, et al. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006; 55: 1985-94.
31. Wolf N, Quaranta M, Prescott NJ, et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 2008; 45: 114-6.